Antimicrobial Agents and Chemotherapy · 2013 · 12 citations · 13 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial InfectionsBeta-lactam ResistanceCarbapenem ResistanceUrinary Tract InfectionsAntimicrobial Resistance In Urinary Tract InfectionsBroad-spectrum AntibioticsCarbapenem AntibioticsExtended-spectrum Beta-lactamase Producing OrganismsExtended-spectrum Beta-lactamase-producing OrganismsKlebsiella Pneumoniae CarbapenemaseKlebsiella Pneumoniae ResistanceSpectrum Of Beta-lactam Antibiotics
Forty-seven extended-spectrum-β-lactamase-positive Klebsiella pneumoniae urinary tract isolates from nonhospitalized patients were identified, and 79% harbored KPC and/or CTX-M β-lactamases. Approximately 90% of the isolates were resistant to trimethoprim-sulfamethoxazole and levofloxacin, and 40% were resistant to a carbapenem, while 92% were susceptible to polymyxin B, 87% were susceptible to tigecycline, and 79% were susceptible to fosfomycin. Increased use of broader-spectrum antibiotics may help to prevent their dissemination and reduce the risk of progression to invasive disease.
13
Brandon Kitchel, J. Kamile Rasheed, Jean B. Patel et al. · Antimicrobial Agents and Chemotherapy · 2009 · 530 citations · Full text
Daryl J. Hoban, Christine Lascols, Lindsay E. Nicolle et al. · Diagnostic Microbiology and Infectious Disease · 2012 · 116 citations
Carl Urban, Patricia A. Bradford, Margareta Tuckman et al. · Clinical Infectious Diseases · 2008 · 86 citations
Roberto Viau, Andrea M. Hujer, Steve H. Marshall et al. · Clinical Infectious Diseases · 2012 · 81 citations · Full text